Skip to main content
Caplight Logo









Seqera

Seqera

Private
BarcelonaAI, Data & Cloud Infrastructurehttps://seqera.io/

Last Round

Series B

May 6, 2025

Total Funding Raised

$53.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Seqera is a bioinformatics software company that provides a platform for data orchestration and workflow management, primarily for the life sciences industry.

Sector

AI, Data & Cloud Infrastructure

Verticals

DevOps & Containers, Biotechnology, Workflow Automation, Cloud Infrastructure

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

workflow orchestrationNextflowbioinformatics pipelinedata orchestrationnf-corecomputational pipelinepipeline portabilitycontainer registryhybrid cloudmulti-cloudbioinformatics platformdata-intensive computingpipeline automationscientific workflowbio-opsreproducible researchHPChigh-performance computing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seqera Comparables

Compare Seqera with similar companies based on industry and business-model similarity.

Seqera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LatchBio
81%
Lifebit
79%
DNAnexus
78%

Seqera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 6, 2025
Series AOct 25, 2022
SeedSep 7, 2021
GrantSep 7, 2021

Key People

Founding team and executive leadership

Evan Floden

CEO & Co-founder

Founding Team

Seqera Investors

Notable investors and investment history

Seqera investors
InvestorRounds
AdditionSeries B, Series A
SNRSeries B
Amino CollectiveSeries B, Series A
SpeedinvestSeries B, Series A, Seed
BoxOne VenturesSeries B, Series A, Seed
Chan Zuckerberg InitiativeGrant, Seed
Talis CapitalSeries B, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 10, 2026

    Added Sano Genetics Limited as a customer.

  • Jan 10, 2026

    Added BioSkryb, Inc. as a customer in Biotechnology.

Seqera Filings

Explore SEC and related filing metadata, where available.

Seqera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Seqera's valuation, stock price, and market status.

Is Seqera a public or private company?

Seqera is a private company.

What is the current stock price of Seqera?

Seqera is a private company with no public stock price. No recent secondary market data is available.

How much is Seqera worth (valuation)?

Valuation information for Seqera is not publicly available.

Can I buy Seqera stock?

Seqera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Seqera's last funding round?

Seqera's most recent funding round was Series B on May 6, 2025.

Who are the main investors in Seqera?

Key investors in Seqera include Addition, Speedinvest, Talis Capital.

Will Seqera IPO soon?

No public IPO plans have been announced for Seqera.

How can I track Seqera secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seqera's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range101
Year Founded2018
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?